Cubist Systematic Strategies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,329
| Closed | -$766K | – | 3236 |
|
|
2021
Q1 | $766K | Buy |
+20,329
| New | +$507K | 0.01% | 1701 |
|
|
2020
Q1 | – | Sell |
-22,818
| Closed | -$105K | – | 2607 |
|
|
2019
Q4 | $105K | Buy |
22,818
+11,764
| +106% | +$46.6K | ﹤0.01% | 2182 |
|
|
2019
Q3 | $43K | Sell |
11,054
-50,610
| -82% | -$278K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $372K | Buy |
61,664
+50,821
| +469% | +$486K | 0.01% | 1668 |
|
|
2019
Q1 | $145K | Sell |
10,843
-27,308
| -72% | -$311K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $355K | Buy |
+38,151
| New | +$454K | 0.02% | 1166 |
|
|
2018
Q2 | – | Sell |
-11,163
| Closed | -$192K | – | 2155 |
|
|
2018
Q1 | $192K | Buy |
11,163
+1,355
| +14% | +$26.4K | 0.01% | 1421 |
|
|
2017
Q4 | $215K | Buy |
9,808
+9,060
| +1,211% | +$291K | 0.01% | 1485 |
|
|
2017
Q3 | $31K | Buy |
+748
| New | +$23.5K | ﹤0.01% | 1758 |
|
|
2017
Q2 | – | Sell |
-3,111
| Closed | -$112K | – | 1956 |
|
|
2017
Q1 | $112K | Buy |
+3,111
| New | +$137K | 0.01% | 1368 |
|
|
2016
Q4 | – | Sell |
-7,142
| Closed | -$375K | – | 1961 |
|
|
2016
Q3 | $375K | Buy |
7,142
+2,811
| +65% | +$134K | 0.02% | 872 |
|
|
2016
Q2 | $179K | Sell |
4,331
-4,041
| -48% | -$176K | 0.01% | 1371 |
|
|
2016
Q1 | $340K | Buy |
8,372
+3,487
| +71% | +$120K | 0.02% | 927 |
|
|
2015
Q4 | $203K | Buy |
4,885
+3,274
| +203% | +$110K | 0.01% | 1348 |
|
|
2015
Q3 | $25K | Sell |
1,611
-1,189
| -42% | -$25.6K | ﹤0.01% | 1769 |
|
|
2015
Q2 | $70K | Buy |
+2,800
| New | +$62.4K | ﹤0.01% | 1671 |
|
|
2015
Q1 | – | Sell |
-9,647
| Closed | -$260K | – | 2159 |
|
|
2014
Q4 | $260K | Buy |
+9,647
| New | +$166K | 0.01% | 1328 |
|
Cubist Systematic Strategies's FPRX Position: Q2 2021 in Review
Cubist Systematic Strategies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 20,329 shares — an estimated $766K sold.
Cubist Systematic Strategies first reported a position in FPRX in Q4 2014 and held it in 17 quarters. The position peaked at $766K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Cubist Systematic Strategies reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Cubist Systematic Strategies sold 20,329 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $766K.
- Cubist Systematic Strategies first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 17 quarters.
- Cubist Systematic Strategies's Five Prime Therapeutics, Inc. position peaked at $766K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.